Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Non-cash Items (2022 - 2024)

bioAffinity Technologies (BIAF) has disclosed Non-cash Items for 3 consecutive years, with $243097.0 as the latest value for Q1 2024.

  • Quarterly Non-cash Items fell 10.39% to $243097.0 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $243097.0 through Mar 2024, down 10.39% year-over-year, with the annual reading at $158332.0 for FY2023, 3.61% down from the prior year.
  • Non-cash Items for Q1 2024 was $243097.0 at bioAffinity Technologies, up from $158332.0 in the prior quarter.
  • The five-year high for Non-cash Items was $647793.0 in Q3 2022, with the low at $158332.0 in Q4 2023.
  • Average Non-cash Items over 3 years is $287185.4, with a median of $254225.0 recorded in 2023.
  • Peak annual rise in Non-cash Items hit 3.61% in 2023, while the deepest fall reached 60.76% in 2023.
  • Over 3 years, Non-cash Items stood at $164255.0 in 2022, then dropped by 3.61% to $158332.0 in 2023, then surged by 53.54% to $243097.0 in 2024.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $243097.0, $158332.0, and $254225.0 for Q1 2024, Q4 2023, and Q3 2023 respectively.